Altamira Therapeutics Ltd. (NASDAQ:CYTO) Q4 2023 Earnings Call Transcript
Operator: Good morning, and welcome to the Altamira Therapeutics Business Update and Full Year 2023 Earnings Conference Call.
Stay updated with breaking news from Nuance Pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Operator: Good morning, and welcome to the Altamira Therapeutics Business Update and Full Year 2023 Earnings Conference Call.
CAMBRIDGE, United Kingdom and NEW YORK, April 09, 2024 (GLOBE NEWSWIRE) -- Artios Pharma Limited (“Artios”), clinical-stage biotech company led ...
Artios Strengthens Board of Directors with Appointment of RTW Investments’ Chris Liu, Ph.D....
Antibe Therapeutics Inc. announced that its previously announced application for an Initial Order under the Companies' Creditors Arrangement Act , has been granted by the Ontario Superior Court of...
Antibe Therapeutics Inc. today announced that it received verbal notice on the afternoon of March 28, 2024 from the U.S. Food and Drug Administration that otenaproxesul has been placed on clinical...